NSD2 and prostate cancer: In a Pten-null murine prostate cancer model, activated AKT could directly phosphorylate WHSC1 to prevent its degradation, and increased WHSC1 further enhanced AKT activity in a feedforward manner to promote prostate cancer metastasis [124].